The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Virtual screening with solvation and ligand-induced complementarity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Cited by
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911795677602 · Cited by 3,771
Principles of docking: An overview of search algorithms and a guide to scoring functions
Halperin, I., Ma, B., Wolfson, H., & Nussinov, R. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10115 · Cited by 1,294
“Schnecke et al. 134,135 have developed Spectitope and Slide.”
BackgroundCombining docking and molecular dynamic simulations in drug design
Alonso, H., Bliznyuk, A. A., & Gready, J. E. (2006) · Medicinal Research Reviews · doi:10.1002/med.20067 · Cited by 759
Virtual ligand screening: strategies, perspectives and limitations
Klebe, G. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.012 · Cited by 664
Structure-based virtual screening: an overview
Lyne, P. D. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02483-2 · Cited by 662
A review of protein-small molecule docking methods
Taylor, R. D., Jewsbury, P. J., & Essex, J. W. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020155510718 · Cited by 655
Advances and Challenges in Protein-Ligand Docking
Huang, S.-Y., & Zou, X. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11083016 · Cited by 639
Receptor–ligand molecular docking
Guedes, I. A., de Magalhães, C. S., & Dardenne, L. E. (2014) · Biophysical Reviews · doi:10.1007/s12551-013-0130-2 · Cited by 606
Structure-Based Virtual Screening: From Classical to Artificial Intelligence
Maia, E. H. B., Assis, L. C., de Oliveira, T. A., da Silva, A. M., & Taranto, A. G. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00343 · Cited by 588
Moitessier, N., Englebienne, P., Lee, D., Lawandi, J., & Corbeil, C. R. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707515 · Cited by 514
Lead discovery using molecular docking
Shoichet, B. K., McGovern, S. L., Wei, B., & Irwin, J. J. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00339-3 · Cited by 501
Variability in docking success rates due to dataset preparation.
Corbeil, C. R., Williams, C. I., & Labute, P. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9570-1 · Cited by 469
FlexE: efficient molecular docking considering protein structure variations
Claußen, H., Buning, C., Rarey, M., & Lengauer, T. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4551 · Cited by 430
Protein Flexibility in Ligand Docking and Virtual Screening to Protein Kinases
Cavasotto, C. N., & Abagyan, R. A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.01.003 · Cited by 412
Modeling water molecules in protein-ligand docking using GOLD.
Verdonk, M. L., Chessari, G., Cole, J. C., Hartshorn, M. J., Murray, C. W., Nissink, J. W. M., Taylor, R. D., & Taylor, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050543p · Cited by 393
Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug Design
Davis, A. M., Teague, S. J., & Kleywegt, G. J. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200539 · Cited by 387
Binding MOAD (Mother Of All Databases)
Hu, L., Benson, M. L., Smith, R. D., Lerner, M. G., & Carlson, H. A. (2005) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20512 · Cited by 328
“In a validation study of the SLIDE docking tool, Zavodszky and Kuhn examined how many binding events could be modeled if an apo protein structure was only allowed minimal side-chain rotations.[166, 167] They compared their SLIDE docking tool to rigid docking with 20 different proteins (having 63 holo structures and 20…”
MethodRapid Context-Dependent Ligand Desolvation in Molecular Docking
Mysinger, M. M., & Shoichet, B. K. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100214a · Cited by 317
Protein flexibility and drug design: how to hit a moving target
Carlson, H. A. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00341-1 · Cited by 314
Target Flexibility: An Emerging Consideration in Drug Discovery and Design
Cozzini, P., Kellogg, G. E., Spyrakis, F., Abraham, D. J., Costantino, G., Emerson, A., Fanelli, F., Gohlke, H., Kuhn, L. A., Morris, G. M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800562d · Cited by 312
Self-citationSanjeevini: a freely accessible web-server for target directed lead molecule discovery
Jayaram, B., Singh, T., Mukherjee, G., Mathur, A., Shekhar, S., & Shekhar, V. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s17-s7 · Cited by 257
A model binding site for testing scoring functions in molecular docking.
Wei, B. Q., Baase, W. A., Weaver, L. H., Matthews, B. W., & Shoichet, B. K. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00777-5 · Cited by 237
“How to model such ordered water molecules in docking remains a matter for future study.(23,41,42) We only note here that neglecting it neither prevented us from finding novel ligands nor predicting their binding geometry.”
BackgroundUnderstanding the challenges of protein flexibility in drug design.
Antunes, D. A., Devaurs, D., & Kavraki, L. E. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1094458 · Cited by 131
Metadata
- Authors
- Schnecke, V., & Kuhn, L. A.
- Venue
- Perspectives in Drug Discovery and Design
- Published
- 2000-12
- Volume
- 20
- Issue
- 1
- Pages
- 171-190
- ISSN
- 0928-2866 (ISSN-L)
- 1573-9023
- OpenAlex
- W2151763847
- Cited by
- 162
- References
- 1
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.